Chronic Myeloid Leukemia - CML
WP study number: |
42201038 |
Working Party: |
CLWP |
Full Title: |
Non-interventional prospective study on the effect of 2nd generation TKI prior to HSCT in CML |
Start Date: |
01 January 2010 |
Key inclusion criteria: |
>18 years old; allogeneic HSCT; CML ; Dasatinib or Nilotinib |
Study status: |
ongoing |
Chief Investigator contact: |
Michael Schleuning |
EBMT contact: |
|
Chronic Lymphocytic Leukemia - CLL WP study number: |
42204420 |
Working Party: |
CLWP |
Full Title: |
Non-interventional prospective study on alloHSCT in 17p- CLL |
Start Date: |
27 August 2010 |
Key inclusion criteria: |
>18 years old; CLL; 1st or 2nd PR or CR at time of transplant |
Study status: |
ongoing |
Chief Investigator contact: |
Johannes Schetelig |
EBMT contact: |
|
Click on the link below to download the relevant documentation:
Study 42204420
Myelodysplastic syndrome - MDS
WP study number: |
42205547 |
Working Party: |
CLWP |
Full Title: |
Non-interventional prospective study on iron toxicity in allogeneic transplanted MDS and CMML |
Start Date: |
01 November 2009 |
Key inclusion criteria: |
>18 years old; MDS; allotx; no CB |
Study status: |
ongoing |
Chief Investigator contact: |
Theo de Witte |
EBMT contact: |
|
Multiple Myeloma - MM
WP study number: |
42206635 |
Working Party: |
CLWP |
Full Title: |
Non-interventional prospective study on prognostic factors for autologous SCT outcomes in MM |
Start Date: |
01 September 2009 |
Key inclusion criteria: |
>18 years old; MM; conditioning with melphalan |
Study status: |
ongoing |
Chief Investigator contact: |
Matthias Klammer |
EBMT contact: |
|
WP study number: |
42206633 |
Working Party: |
CLWP |
Full Title: |
Non-interventional prospective study on allogeneic transplants in AL Amyloidosis |
Start Date: |
December 2009 |
Key inclusion criteria: |
Patients 18-60 years old who receive allo-tx in AL Amyloidosis. Eligible patients in follow up are also welcome. |
Study status: |
ongoing |
Chief Investigator contact: |
Stefan Schönland |
EBMT contact: |
|